Ward W F, Molteni A, Ts'ao C, Solliday N H
Radiat Res. 1984 May;98(2):397-406.
To determine whether D-penicillamine, known to reduce fibrosis in irradiated rat lung (W. F. Ward, A. Shih - Hoellwarth , and R. D. Tuttle , Radiology 146, 533-537, 1983), also ameliorates radiation injury in the pulmonary endothelium, we measured angiotensin-converting enzyme (ACE) activity, plasminogen activator (PLA) activity, and prostacyclin (PGI2) production in the lungs of penicillamine-treated (10 mg/day, po, continuous after irradiation) and untreated rats from 2 weeks to 6 months after a single dose of 25 Gy of 60Co gamma rays to the right hemithorax. Both ACE and PLA activity in the irradiated right lung of untreated rats decreased dramatically between the 1st and 2nd months after exposure, then reached a plateau through 6 months at approximately 25 and 50% of the normal level, respectively. For the first 2 months after irradiation, penicillamine-treated animals exhibited significantly (P less than 0.05) higher activities of both ACE and PLA than did untreated rats. From 3 to 6 months after irradiation, however, the only significant drug effect on these enzymes was a 25% increase in PLA activity at 6 months. PGI2 production by the irradiated lung of untreated rats increased continuously, and at 6 months was approximately 10 times higher than normal. Penicillamine significantly (P less than 0.05) reduced this hypersecretion, and at 6 months after irradiation, PGI2 production by the lungs of drug-treated rats was only half that of untreated animals. In contrast, the drug had no significant effect on enzyme activities in the lungs of sham-irradiated rats. Thus the antifibrotic agent D-penicillamine delays the onset of radiation-induced enzyme dysfunction in the pulmonary endothelium. In addition at 6 months after irradiation, the lungs of penicillamine-treated rats exhibit 25% more PLA activity and only half as severe a hypersecretion of PGI2 as do the lungs of untreated animals. The drug is most effective in ameliorating endothelial damage during the first 2 months after irradiation, preceding the development of interstitial fibrosis. However, the effect of this penicillamine regimen on pulmonary endothelial function is not as large as its effect on collagen accumulation in irradiated rat lung.
已知D-青霉胺可减轻照射后大鼠肺组织的纤维化(W.F.沃德、A.施-赫尔沃思和R.D.塔特尔,《放射学》146卷,533 - 537页,1983年),为确定其是否也能改善肺内皮细胞的辐射损伤,我们测量了经青霉胺处理(10毫克/天,口服,照射后持续给药)和未处理大鼠在单次给予右半胸25戈瑞60Coγ射线后2周龄至6月龄时肺组织中血管紧张素转换酶(ACE)活性、纤溶酶原激活物(PLA)活性以及前列环素(PGI2)的生成量。未处理大鼠照射后的右肺中,ACE和PLA活性在照射后第1个月至第2个月间急剧下降,然后在6个月内分别维持在正常水平的约25%和50%并达到平台期。照射后的前2个月,经青霉胺处理的动物ACE和PLA活性均显著高于(P<0.05)未处理大鼠。然而,在照射后3至6个月,该药物对这些酶的唯一显著作用是在6个月时PLA活性增加25%。未处理大鼠照射后的肺组织中PGI2生成持续增加,在6个月时约为正常水平的10倍。青霉胺显著(P<0.05)降低了这种高分泌,在照射后6个月时,经药物处理大鼠肺组织中PGI2的生成量仅为未处理动物的一半。相比之下,该药物对假照射大鼠肺组织中的酶活性无显著影响。因此,抗纤维化药物D-青霉胺可延迟辐射诱导的肺内皮细胞酶功能障碍的发生。此外,在照射后6个月时,经青霉胺处理大鼠的肺组织PLA活性比未处理动物高25%,PGI2高分泌程度仅为未处理动物的一半。该药物在照射后前2个月、在间质纤维化形成之前改善内皮损伤最为有效。然而,这种青霉胺给药方案对肺内皮功能的影响不如其对照射后大鼠肺组织中胶原积累的影响大。